These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9062875)

  • 1. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.
    Washington K; Telen MJ; Gottfried MR
    Liver; 1997 Feb; 17(1):17-23. PubMed ID: 9062875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
    Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
    Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
    Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
    Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
    Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
    Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.
    Iyer A; Robert ME; Bifulco CB; Salem RR; Jain D
    Hum Pathol; 2008 Sep; 39(9):1370-7. PubMed ID: 18602664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
    Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
    Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative lengthening of telomeres in primary hepatic neoplasms.
    Yasir S; Thompson S; Chen ZE; Knudson R; Knutson D; Kloft-Nelson S; Graham RP; Jain D; Simon SM; Wu TT; Torbenson M
    Hum Pathol; 2023 Jan; 131():79-86. PubMed ID: 36370823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.
    Takahashi Y; Dungubat E; Kusano H; Ganbat D; Tomita Y; Odgerel S; Fukusato T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma.
    Sabit H; Tsuneyama K; Shimonishi T; Harada K; Cheng J; Ida H; Saku T; Saito K; Nakanuma Y
    Pathol Int; 2001 Apr; 51(4):248-56. PubMed ID: 11350606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.